Arizona State Retirement System raised its position in shares of Xylem Inc. (NYSE:XYL) by 0.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,100 shares of the company’s stock after buying an additional 200 shares during the period. Arizona State Retirement System’s holdings in Xylem were worth $2,313,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of XYL. FMR LLC raised its position in Xylem by 74.1% in the second quarter. FMR LLC now owns 5,956,085 shares of the company’s stock worth $265,940,000 after buying an additional 2,534,911 shares during the period. Bessemer Group Inc. increased its stake in shares of Xylem by 43,570.6% in the second quarter. Bessemer Group Inc. now owns 1,593,977 shares of the company’s stock worth $71,171,000 after buying an additional 1,590,327 shares in the last quarter. Janus Capital Management LLC increased its stake in shares of Xylem by 225.0% in the second quarter. Janus Capital Management LLC now owns 1,215,657 shares of the company’s stock worth $54,279,000 after buying an additional 841,565 shares in the last quarter. American Century Companies Inc. increased its stake in shares of Xylem by 190.6% in the second quarter. American Century Companies Inc. now owns 1,161,281 shares of the company’s stock worth $51,851,000 after buying an additional 761,695 shares in the last quarter. Finally, Fiera Capital Corp bought a new stake in shares of Xylem during the second quarter worth about $33,175,000. 84.62% of the stock is owned by hedge funds and other institutional investors.
Xylem Inc. (NYSE:XYL) opened at 52.92 on Friday. The stock has a market cap of $9.49 billion, a price-to-earnings ratio of 29.37 and a beta of 1.18. The firm has a 50-day moving average price of $50.29 and a 200 day moving average price of $48.28. Xylem Inc. has a 1-year low of $31.67 and a 1-year high of $54.99.
Xylem (NYSE:XYL) last issued its earnings results on Tuesday, November 1st. The company reported $0.54 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.01. The company earned $897 million during the quarter, compared to analysts’ expectations of $913.53 million. Xylem had a return on equity of 16.38% and a net margin of 8.83%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 EPS. On average, equities research analysts anticipate that Xylem Inc. will post $2.04 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Wednesday, November 9th will be issued a $0.1549 dividend. This represents a $0.62 annualized dividend and a yield of 1.17%. The ex-dividend date of this dividend is Monday, November 7th. Xylem’s payout ratio is currently 34.44%.
A number of analysts recently issued reports on the company. RBC Capital Markets set a $51.00 price target on Xylem and gave the stock a “buy” rating in a research report on Tuesday, August 16th. Stifel Nicolaus raised their price target on Xylem from $47.00 to $48.00 and gave the stock a “hold” rating in a research report on Wednesday, November 2nd. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $58.00 price target (up from $55.00) on shares of Xylem in a research report on Monday, November 21st. Canaccord Genuity restated a “hold” rating and issued a $50.00 price target (up from $45.00) on shares of Xylem in a research report on Tuesday, August 16th. Finally, Janney Montgomery Scott upgraded Xylem from a “neutral” rating to a “buy” rating and raised their price target for the stock from $50.00 to $52.00 in a research report on Wednesday, November 2nd. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Xylem presently has a consensus rating of “Buy” and an average target price of $47.15.
In other Xylem news, SVP Claudia S. Toussaint sold 5,300 shares of the company’s stock in a transaction on Friday, November 4th. The stock was sold at an average price of $47.27, for a total value of $250,531.00. Following the completion of the sale, the senior vice president now directly owns 44,033 shares in the company, valued at approximately $2,081,439.91. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Colin R. Sabol sold 27,473 shares of the company’s stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $50.91, for a total value of $1,398,650.43. Following the completion of the sale, the insider now owns 65,530 shares of the company’s stock, valued at $3,336,132.30. The disclosure for this sale can be found here. 0.77% of the stock is owned by company insiders.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.